Focused on the research and development and production of resin materials and resin end products - Hebei Lijiang
-
AboutHebei Lijiang Biotechnology Co., Ltd. is a new material manufacturer specializing in the production of functional special ion exchange resins and disposable blood perfusion devices. It is a modern high-tech enterprise integrating the research and development, production, sales, and service of resin materials and resin end products. The company was established in April 2014 with a registered capital of 52 million yuan. It plans to cover an area of 267 acres and is located in the High-tech Industrial Park of Weixian County, Hebei Province—New Material Demonstration Park. The total investment is 510 million yuan. It is a council member unit of the Ion Exchange Resin Branch of the China Membrane Industry Association.
-
Product
-
BlogsThe company will focus on the high-end market, with the purpose of serving society, solidly carrying out technological innovation and product promotion, continuously improving the development and expansion of ion exchange resin products in emerging application fields, thereby promoting the upgrading and development of related industries.
-
Company AlbumThe current phase of construction has been fully completed and put into operation, featuring a comprehensive workshop with 42 production lines for functional ion exchange resins with an annual output of 16,800 tons and a production capacity of 30,000 tons, a wastewater treatment plant with an annual treatment capacity of 403,000 tons, and a workshop producing 5,000 tons of medical-grade magnesium sulfate annually. Trial production began in July 2016, with official production starting in January 2017.
Warm congratulations on the grand opening ceremony of our company's "Disposable Blood Perfusion Device" project
Release Time:
2019-03-12
On the morning of February 25, 2019, the groundbreaking ceremony for our company's disposable blood perfusion device project was grandly held at the company's construction base in the park. Gao Changying, Secretary of the Weixian High-tech Zone Management Committee, Liu Jinjian, Director of the Weixian Transportation Bureau, our company's Chairman Mao Jiang, General Manager Dong Yihong, heads of relevant county units, and employee representatives attended the groundbreaking ceremony.
The disposable blood perfusion device is an extension of our company's high-end resin application industry chain and is a high-profit product in the rapidly growing medical market. Our company relies on its potential talents, technology, and product advantages, aiming to benefit humanity by alleviating the suffering of patients with uremia, lupus erythematosus, poisoning, and other conditions. As a public welfare project, it has received high attention from the Hebei Provincial Department of Science and Technology, the Health and Family Planning Commission, and other departments. The project has a total planned investment of 200 million RMB, including the construction of a super-clean production workshop, a supporting Class 100 ultra-clean laboratory, and two pilot production lines. The project is expected to be completed and put into operation in 2021, with an annual production capacity of 1 million disposable blood perfusion devices and an output value of 500 million RMB.
The commencement and completion of this project will undoubtedly usher in a new chapter in our company's development and will also make us one of the larger blood perfusion device manufacturers. Our company will further refine the construction plan, work at full speed, live up to the mission, and make every effort to promote the early completion of the project, thereby making due contributions to the development of the medical industry.
Keyword:
Recommended Reading
24-05-14 14:37:56
